Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.


By Published on .

Schering-Plough HealthCare Products shifted over $18 million in over-the-counter drug brand advertising from its agency of approximately 30 years, Warwick Baker & O'Neill, to Messner Vetere Berger McNamee Schmetterer/

Euro RSCG, both New York.

The company in a statement said "the consolidation is consistent with our strategic goal of accelerating growth through focus and efficiency."

Warwick is now off the roster.

The shift involves Drixoral, Chlor-Trimeton, Coricidin, Di-Gel, Tinactin, Lotrimin AF and Gyne-Lotrimin brands.

Most Popular
In this article: